このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Comparison of PNF and Non-Immersive Virtual Reality-Assisted PNF Exercises in Individuals With Adhesive Capsulitis

2026年11月11日 更新者:Mehmet CANLI、Kirsehir Ahi Evran Universitesi

Comparison of the Effects of Proprioceptive Neuromuscular Facilitation Exercises and Non-Immersive Virtual Reality-Assisted Proprioceptive Neuromuscular Facilitation Exercises Added to Conventional Physiotherapy in Individuals With Adhesive Capsulitis: A Randomized Controlled Trial

his study aims to compare the effects of conventional physiotherapy combined with Proprioceptive Neuromuscular Facilitation (PNF) exercises and conventional physiotherapy combined with non-immersive virtual reality-assisted PNF exercises in individuals with adhesive capsulitis (frozen shoulder).

A total of 60 individuals aged 40-65 years who have been diagnosed with adhesive capsulitis will participate in this randomized controlled trial. Participants will be randomly assigned to one of two groups. The first group will receive conventional physiotherapy combined with traditional PNF exercises, while the second group will receive conventional physiotherapy combined with non-immersive virtual reality-assisted PNF exercises.

Both groups will receive treatment three times per week for six weeks, for a total of 18 sessions. Each session will last 60 minutes, including 45 minutes of conventional physiotherapy and 15 minutes of either traditional PNF exercises or virtual reality-assisted PNF exercises.

Participants will be evaluated before treatment and immediately after the six-week intervention. The assessments will examine pain intensity, pain catastrophizing, fear of movement (kinesiophobia), upper extremity function, and shoulder-specific pain and disability.

The study aims to determine whether non-immersive virtual reality-assisted PNF exercises provide additional benefits compared with traditional PNF exercises when combined with conventional physiotherapy in individuals with adhesive capsulitis.

調査の概要

詳細な説明

Adhesive capsulitis is a musculoskeletal condition characterized by shoulder pain, progressive restriction of active and passive range of motion, and limitations in daily activities. Although conventional physiotherapy is commonly used to improve pain and shoulder function, additional rehabilitation approaches may provide further benefits.

Proprioceptive Neuromuscular Facilitation (PNF) is a therapeutic exercise approach involving spiral and diagonal movement patterns designed to improve neuromuscular control, coordination, and functional movement. Non-immersive virtual reality-assisted rehabilitation allows individuals to perform therapeutic movements in an interactive digital environment while receiving real-time visual feedback.

This study is designed as a two-arm, parallel-group, randomized controlled trial to investigate whether integrating non-immersive virtual reality into PNF exercises provides additional clinical and psychosocial benefits compared with traditional PNF exercises in individuals with adhesive capsulitis.

The interventions will incorporate upper extremity PNF diagonal movement patterns. In the traditional PNF group, these movements will be performed under the guidance of a physiotherapist using established PNF techniques. In the virtual reality-assisted PNF group, corresponding movement patterns will be performed through an interactive screen-based system that tracks upper extremity movements and provides real-time visual feedback.

The study will examine changes in pain intensity, pain catastrophizing, kinesiophobia, upper extremity function, and shoulder-specific pain and disability. Outcomes will be assessed using the Visual Analog Scale (VAS), Pain Catastrophizing Scale (PCS), Tampa Scale for Kinesiophobia (TSK), Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH), and Shoulder Pain and Disability Index (SPADI).

By comparing these approaches, the study seeks to determine the potential contribution of non-immersive virtual reality to PNF-based rehabilitation and provide evidence regarding its clinical applicability in individuals with adhesive capsulitis.

研究の種類

介入

入学 (推定)

60

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

40年~65年 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

Individuals aged 40-65 years.

Diagnosis of adhesive capsulitis confirmed by a specialist physician.

Restriction of both active and passive range of motion in the affected shoulder.

Significant limitation of shoulder external rotation compared with the contralateral side.

Ability to understand and follow verbal and visual instructions provided during the study.

Willingness to participate regularly in the six-week treatment program.

Voluntary participation in the study and provision of written informed consent.

Exclusion Criteria:

Presence of a full-thickness rotator cuff tear, advanced glenohumeral osteoarthritis, fracture, dislocation, or malignancy in the affected shoulder.

History of previous surgery involving the affected shoulder.

Cervical radiculopathy or other neurological disorders that may affect shoulder movements.

Presence of inflammatory rheumatic diseases.

Bilateral adhesive capsulitis.

History of injection therapy in the shoulder region within the previous three months.

Participation in another shoulder rehabilitation program during the study period.

Uncontrolled cardiovascular, neurological, or systemic diseases that may interfere with exercise participation.

Severe uncorrected visual impairment that prevents participants from viewing or following the non-immersive virtual reality application.

Cognitive impairment severe enough to interfere with communication or completion of assessment questionnaires.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:Conventional Physiotherapy + Proprioceptive Neuromuscular Facilitation (PNF)

Participants in this group will receive conventional physiotherapy combined with traditional Proprioceptive Neuromuscular Facilitation (PNF) exercises. Each treatment session will last 60 minutes, consisting of 45 minutes of conventional physiotherapy and 15 minutes of therapist-guided PNF exercises. The PNF program will include upper extremity diagonal movement patterns (D1 and D2 flexion and extension). Treatment will be administered three times per week for six weeks, for a total of 18 sessions.

Participants will receive 45 minutes of conventional physiotherapy, including 15 minutes of superficial heat application, 15 minutes of transcutaneous electrical nerve stimulation (TENS), and 15 minutes of therapeutic exercises. Therapeutic exercises will include Codman pendulum exercises, active-assisted shoulder range of motion exercises, and stretching of the posterior shoulder capsule and pectoral muscles.

Following conventional physiotherapy, participants will perform 15 minutes of therapist-guided Proprioceptive Neuromuscular Facilitation (PNF) exercises involving upper extremity D1 and D2 flexion-extension diagonal patterns. Each diagonal pattern will be performed in two sets of 10 repetitions, with 30 seconds of rest between sets. Rhythmic initiation and progressive pain-free manual resistance will be applied according to individual tolerance.

Treatment will be administered three times per week for six weeks, totaling 18 sessions.

実験的:Conventional Physiotherapy + Non-Immersive Virtual Reality-Assisted PNF

Participants in this group will receive conventional physiotherapy combined with non-immersive virtual reality-assisted Proprioceptive Neuromuscular Facilitation (PNF) exercises. Each treatment session will last 60 minutes, consisting of 45 minutes of conventional physiotherapy and 15 minutes of virtual reality-assisted PNF exercises. The exercises will involve upper extremity diagonal movement patterns (D1 and D2 flexion and extension) performed using a screen-based interactive system that provides real-time visual feedback. Treatment will be administered three times per week for six weeks, for a total of 18 sessions.

Participants will receive the same 45-minute conventional physiotherapy program, including 15 minutes of superficial heat application, 15 minutes of transcutaneous electrical nerve stimulation (TENS), and 15 minutes of therapeutic exercises consisting of Codman pendulum exercises, active-assisted shoulder range of motion exercises, and stretching exercises.

Following conventional physiotherapy, participants will perform 15 minutes of non-immersive virtual reality-assisted Proprioceptive Neuromuscular Facilitation (PNF) exercises. Upper extremity D1 and D2 flexion-extension diagonal movement patterns will be performed using a screen-based interactive virtual environment. A motion-tracking system will transfer upper extremity movements to virtual targets and provide real-time visual feedback regarding movement direction and completion.

Treatment will be administered three times per week for six weeks, totaling 18 sessions.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change in Shoulder Pain and Disability Index (SPADI) Total Score
時間枠:6 weeks

Shoulder-specific pain and disability will be assessed using the Shoulder Pain and Disability Index (SPADI). The SPADI consists of 13 items divided into two subscales: pain (5 items) and disability (8 items). Pain and disability subscale scores are calculated separately, and a total SPADI score is obtained. Scores range from 0 to 100, with higher scores indicating greater shoulder pain and functional disability. The primary outcome will be the change in the SPADI total score from baseline to the end of the six-week intervention.

6 weeks

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in Pain Intensity Assessed by the Visual Analog Scale (VAS)
時間枠:6 weeks

Pain intensity will be assessed using the Visual Analog Scale (VAS) under three conditions: at rest, during activity, and at night. Participants will indicate their pain intensity experienced during the previous week on three separate 10-cm horizontal lines, ranging from 0 (no pain) to 10 (unbearable pain). The distance from the starting point to the marked position will be measured in centimeters. Higher scores indicate greater pain intensity. Changes in resting, activity-related, and nighttime pain will be evaluated separately from baseline to the end of the six-week intervention.

6 weeks
Change in Tampa Scale for Kinesiophobia (TSK) Total Score
時間枠:6 weeks

Kinesiophobia will be assessed using the Tampa Scale for Kinesiophobia (TSK), which measures fear of movement associated with pain or anticipated reinjury. The scale consists of 17 items, each scored from 1 (strongly disagree) to 4 (strongly agree). After reverse-scoring four items, the total score ranges from 17 to 68, with higher scores indicating greater fear of movement. Changes in the total TSK score will be assessed from baseline to the end of the six-week intervention.

6 weeks
Change in Disabilities of the Arm, Shoulder and Hand (DASH) Score
時間枠:6 week

Upper extremity function will be assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. The DASH consists of 30 items evaluating difficulties in performing daily activities, limitations in social and occupational functioning, pain, and other upper extremity symptoms. Each item is scored from 1 to 5, and the total score is transformed to a scale ranging from 0 to 100. A score of 0 indicates no disability, while 100 indicates the greatest level of disability. Changes in the DASH score will be assessed from baseline to the end of the six-week intervention.

6 week
Change in Pain Catastrophizing Scale (PCS) Total Score
時間枠:6 weeks

Pain catastrophizing will be assessed using the Pain Catastrophizing Scale (PCS). The scale consists of 13 items divided into three subscales: rumination, magnification, and helplessness. Each item is scored from 0 (not at all) to 4 (all the time), resulting in a total score ranging from 0 to 52. Higher scores indicate greater levels of pain catastrophizing. Changes in the total PCS score will be assessed from baseline to the end of the six-week intervention.

6 weeks

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Mehmet CANLI, PhD.、Kirsehir Ahi Evran Universitesi

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年12月15日

一次修了 (推定)

2027年5月1日

研究の完了 (推定)

2027年5月15日

試験登録日

最初に提出

2026年11月11日

QC基準を満たした最初の提出物

2026年11月11日

最初の投稿 (実際)

2026年11月17日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月17日

QC基準を満たした最後の更新が送信されました

2026年11月11日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

追加の関連 MeSH 用語

その他の研究ID番号

  • 43834581758%

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する